Indianapolis-based drug giant Eli Lilly and Co. on Monday announced an agreement to acquire cancer-drug developer Ajax Therapeutics Inc. in a deal worth up to $2.3 billion. The acquisition is the ...

Eli Lilly is continuing its Massachusetts shopping spree, picking up a Cambridge biotech focused on blood cancer treatments for up to $2.3 billion. It's the pharma giant's second local blood ...

Chelsea sack head coach Liam Rosenior after losing five consecutive Premier League matches without scoring for the first time ...

Follow live BBC coverage, text commentary, score updates and match stats from Aston Villa vs Nottingham Forest in the.

Two teams which produced a 5-4 instant classic last week will take centre stage on Wednesday for the second act of their ...

Your data pipeline isn't just a back-end function. It's the intelligence layer that decides whether your business acts before competitors do or catches up after the fact. Finding a trusted full ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

By Christy Santhosh April 27 (Reuters) - Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Everything you need to know about how to watch Ajax in the Eredivisie and all major competitions. A team with a lot of legacy, Ajax have a huge fan base in the USA. Hence, GOAL brings to you all the ...

Eli Lilly LLY0.87%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...